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Brener et al. (1) show in a substudy of INFUSE-AMI (Intra-
coronary Abciximab and Aspiration Thrombectomy in Patients
With Large Anterior Myocardial Infarction) trial that myocardial
blush grade (MBG) 2/3 in a relatively small study population
of 452 patients is associated with smaller infarct size, less micro-
vascular obstruction, improved ejection fraction as assessed by
contrast-enhanced cardiac magnetic resonance, and, strikingly,
signiﬁcantly lower 30-day mortality.
As mentioned by the authors in the limitations section of
the study, ST-segment resolution (STR) is a powerful predictor of
myocardial salvage and of clinical outcome, as recently conﬁrmed
in an electrocardiogram substudy of the HORIZONS-AMI
(Harmonizing Outcomes With Revascularization and Stents in
Acute Myocardial Infarction). In this study, absent STR at 60 min
after primary percutaneous coronary intervention was a signiﬁcant
independent predictor of major adverse cardiovascular events and
target vessel revascularization at 3 years (2).
In the present study the differences in MBG were associated
with signiﬁcantly better clinical outcomes, and, furthermore, the
robust association between MBG and infarct size was independent
of STR. Unfortunately, the authors do not report whether STR,
as mentioned as a very important independent predictor of major
adverse cardiovascular events, is associated with better clinical
outcomes. Providing these additional data on the association of
STR with clinical outcomes would be helpful to shape future
surrogate endpoints of clinical trials.
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We thank Dr. Haeck for his interest in our paper (1) and for his
insightful comments. Assessing success of myocardial reperfusion
in ST-segment elevation myocardial infarction is critical to
improving outcome. As we noted in Table 3 of our paper (1), there
was no difference in the incidence of ST-segment resolution (STR)
>70% between patients with and without adequate myocardial
blush grade (MBG) (53.3% vs. 47.4%, p ¼ 0.35). We further
explored the association between electrocardiographic parameters,
infarct size, and outcome in a separate paper (2). In short, STR did
not correlate with mortality at 30 days, but new Q waves at 60 min
post-percutaneous coronary intervention did (p ¼ 0.04). We
also assessed the complementary value of STR and MBG in
a much larger cohort of patients enrolled in the HORIZONS AMI
(Harmonizing Outcomes with RevasculariZatiON and Stents in
Acute Myocardial Infarction) trial (3). We demonstrated that there
is discordance between MBG 2/3 and STR 50% in 30% of
patients. MBG 2/3 was achieved in 77.7% of patients and STR
50% was achieved in 75.1% of patients. By multivariable analysis
(including MBG and STR), MBG 2/3 was an independent
predictor of lower mortality at 3 years (4.4% vs. 8.4%, adjusted
hazard ratio [HR]: 0.57 [0.39 to 0.82], p ¼ 0.003). In contrast,
STR 50% was not predictive of mortality (5.1% vs. 5.9%,
adjusted HR: 1.11 [0.68 to 1.56], p ¼ 0.89). We believe that in
aggregate, the data support the concept that MBG and STR
represent different aspects of myocardial reperfusion. MBG reﬂects
predominantly the integrity of the microcirculation, but not
necessarily the health and stability of the myocardial cells in that
territory. STR is principally indicative of the restoration of the
transmembrane potential in viable myocardium, even in the pres-
ence of compromised microcirculation. The 2 measures offer
important, but not mutually exclusive, information.
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